Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors

J Psychiatry Neurosci. 1995 Jan;20(1):11-9.

Abstract

The uptake of [3H]5-HT and the density (Bmax) as well as affinity (Kd) of 5-HT uptake sites labelled with [3H]paroxetine and of 5-HT2 receptors labelled by [3H]LSD were determined in platelets from 25 medication-free patients with major depression and 20 normal controls. The density (Bmax) of 5-HT2 receptors was found to be significantly increased (by 52%) in platelets from depressed patients, particularly females. No changes were found in the affinity (Kd) of 5-HT2 receptors and in 5-HT uptake or [3H]paroxetine binding parameters. Density of 5-HT2 receptors positively correlated with that of [3H]paroxetine sites in control but not in depressed subjects. No correlation was found between the HAMD scores and Bmax of [3H]LSD binding. The results suggest that upregulation of platelet 5-HT2 receptors is a useful biological marker in major depression, particularly in females.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / blood
  • Blood Platelets / metabolism*
  • Depressive Disorder / blood*
  • Depressive Disorder / diagnosis
  • Depressive Disorder / psychology
  • Female
  • Humans
  • Lysergic Acid Diethylamide / pharmacokinetics
  • Male
  • Middle Aged
  • Paroxetine / pharmacokinetics
  • Radioligand Assay
  • Receptors, Serotonin / classification
  • Receptors, Serotonin / physiology*
  • Sex Factors
  • Up-Regulation / physiology

Substances

  • Biomarkers
  • Receptors, Serotonin
  • Paroxetine
  • Lysergic Acid Diethylamide